Our study showed that the CD4 + T cell was an independent predictor of both immunotherapy efficacy and prognosis in advanced gastric cancer, suggesting the indispensable tumor suppressive capacity of CD4 + T cells in immunotherapy. This evidence concerns the gene CD4 and neoplasm.